Challenges and Opportunities: Steps to Maximizing Cancer Immunotherapy Regimens

Access Course


Experts discuss the latest research in the use of cancer immunotherapies.


This activity is intended for oncologists, pathologists, dermatologists, and other healthcare professionals who manage patients with cancer.


The goal of this activity is to discuss emerging strategies in the use of immunotherapy for cancer treatment.






Approximate Time to Complete: 30 minutes


Credit Available: Dec. 19, 2018- Dec. 19, 2019


Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Have increased knowledge regarding the association between combination therapy and immune-related adverse events that may be associated with use of emerging cancer immunotherapy strategies
  • Have increased knowledge regarding the use of combination regimens with multiple mechanisms of action as strategies for treating cancer
American Board of Internal Medicine
ABIM MOC Part 2 Credits: 0.50
(0.5 contact hours are in the area of pharmacology)
Accreditation Council for Continuing Medical Education (MD/DO)
AMA PRA Category 1 Credit(s)™: 0.50